François, Katrien O <br/><br/>
Simian immunodeficiency virus is susceptible to inhibition by carbohydrate-binding agents in a manner similar to that of HIV: implications for further preclinical drug development.  [electronic resource] 

 -  Molecular pharmacology  Aug 2008 
 - 330-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-0111 
<br/><br/><label>Standard No.: </label>10.1124/mol.108.047621  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anthracyclines--metabolism<br/>Antiviral Agents--metabolism<br/>Binding Sites--drug effects<br/>Carbohydrate Metabolism--drug effects<br/>Cells, Cultured<br/>Drug Design<br/>Drug Evaluation, Preclinical--trends<br/>Drug Resistance, Viral--drug effects<br/>HIV--drug effects<br/>Humans<br/>Plant Lectins--pharmacokinetics<br/>Simian Immunodeficiency Virus--drug effects